10.	Related Party.

February 9, 2018,

Dr. Chen received

1,000,000

shares of ABI common stock as repayment for advancing

$187,500

to ABI between

March 18, 2016,

and

April 7, 2016,

as operating funds for ABI. The stock was issued at a price of

$.1875

per share.

March 27, 2018,

effective as of

January 1, 2018,

the Board of Directors approved a resolution whereby Dr. Chen's annual compensation was changed to

$240,000

cash per annum and

$100,000

per annum payable in the Company's unregistered, voting common stock. The Board also approved the change in compensation to Bernard Cohen to

$70,000

cash per annum and

$12,000

per annum payable in the Company's unregistered, voting common stock. The cash compensation is to be paid on the normal payroll cycle of

15th

and

31st

of each month and stock compensation to be paid quarterly. Shares are to be priced at the average of all trading day closing quotes on the OTC-BB for the month preceding date of issuance, with such shares to be issued on the

first

business day after the close of each calendar quarter or as soon thereafter as practicable. During the period ended

June 30, 2018,

the Company has issued an aggregate of

86,698

shares of common stock valued at

$21,250

as payment for the

fourth

quarter

2017

accrual. As of

June 30, 2018,

the Company has accrued

$56,000

in Accounts Payable and Accrued Expenses representing

first

and

second

quarters of

2018

shares that have

not

been issued.

April 1, 2018,

Dr. Stephen T. Chen, ABI Chairman, CEO, and President, a related party, executed and presented a Promissory Note Conversion Notice exercising his option to convert

$178,125

Principal Amount of the Note bearing a balance of

$284,555

into ABI Common Stock Shares in accordance with the terms of the Note. ABI made the conversion, reduced the debt accordingly, and issued the shares as requested by Dr. Chen.